Literature DB >> 11449787

Otolaryngologic manifestations of Down syndrome.

G Kanamori1, M Witter, J Brown, L Williams-Smith.   

Abstract

The DS patient has clear anatomic differences in the head and neck region when compared with the general population. These anomalies include a flat occiput, oblique palpebral fissures, epicanthal folds, speckled irides, a protruding tongue, prominent malformed ears, and a flat nasal bridge. Congenital otologic anomalies and acquired conditions such as otitis media are also more frequently observed in the DS population. The DS patient is predisposed to obstructive sleep apnea, and the diagnosis of sleep apnea in DS patients is more likely to be delayed. A child with DS who has a narrowed nasopharynx, large tongue, and a subglottis which is smaller than normal must be given special consideration at the time of intubation. Such a patient requires an endotracheal tube two sizes smaller than the standard size appropriate for the patient's age. The child should also be suspected of having and be evaluated for obstructive sleep apnea, to ensure that appropriate precautions are taken in the perioperative period. Finally, any DS patient undergoing preoperative evaluation for a general anesthetic should have a careful assessment of the cervical spine to avoid dislocation or spinal cord injury. Hearing loss may be suspected in any congenital syndrome. In DS, there is a clearly increased incidence of congenital temporal bone anomalies, external auditory canal stenosis, and otitis media. All DS patients should undergo hearing assessment in the neonatal period, with follow-up as appropriate. Aggressive treatment of conductive hearing loss and early amplification may be necessary to maximize speech and language development.

Entities:  

Mesh:

Year:  2000        PMID: 11449787     DOI: 10.1016/s0030-6665(05)70281-4

Source DB:  PubMed          Journal:  Otolaryngol Clin North Am        ISSN: 0030-6665            Impact factor:   3.346


  6 in total

1.  [Hearing impairment in children and adolescents with Down's syndrome].

Authors:  C Hess; F Rosanowski; U Eysholdt; M Schuster
Journal:  HNO       Date:  2006-03       Impact factor: 1.284

2.  Down Syndrome as an indicator for pediatric otolaryngologic procedures.

Authors:  Terral A Patel; Shaun A Nguyen; David R White
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2018-07-09       Impact factor: 1.675

3.  Otitis media in a mouse model for Down syndrome.

Authors:  Fengchan Han; Heping Yu; Jiangping Zhang; Cong Tian; Cecilia Schmidt; Casey Nava; Muriel T Davisson; Qing Y Zheng
Journal:  Int J Exp Pathol       Date:  2009-10       Impact factor: 1.925

Review 4.  Severe upper airway obstruction during sleep.

Authors:  H William Bonekat; Kimberly A Hardin
Journal:  Clin Rev Allergy Immunol       Date:  2003-10       Impact factor: 8.667

5.  High prevalence of sleep disorders and associated comorbidities in a community sample of children with Down syndrome.

Authors:  Claire A Hoffmire; Caroline I Magyar; Heidi V Connolly; I Diana Fernandez; Edwin van Wijngaarden
Journal:  J Clin Sleep Med       Date:  2014-04-15       Impact factor: 4.062

6.  Specific Susceptibility to COVID-19 in Adults with Down Syndrome.

Authors:  Tomer Illouz; Arya Biragyn; Milana Frenkel-Morgenstern; Orly Weissberg; Alessandro Gorohovski; Eugene Merzon; Ilan Green; Florencia Iulita; Lisi Flores-Aguilar; Mara Dierssen; Ilario De Toma; Hefziba Lifshitz; Stylianos E Antonarakis; Eugene Yu; Yann Herault; Marie-Claude Potier; Alexandra Botté; Randall Roper; Benjamin Sredni; Ronit Sarid; Jacqueline London; William Mobley; Andre Strydom; Eitan Okun
Journal:  Neuromolecular Med       Date:  2021-03-04       Impact factor: 3.843

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.